Is Mesoblast the biomedical stock you have to have? + Freelancer: stock on the way up?

Advertisement

BEGIN ARTICLE PREVIEW:

Peter Switzer is joined by Burman Invest’s Julia Lee, Freelancer.com’s Matt Barrie, Vanguard’s Robin Bowerman and Switzer’s Paul Rickard.

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE